stockportfolio.pro
ANI Pharmaceuticals, Inc. Total Debt 2009–2025
ANI Pharmaceuticals, Inc. (ANIP) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $291.84M | -5.6% |
| FY 2024 | $309.11M | +8.5% |
| FY 2023 | $284.82M | -0.3% |
| FY 2022 | $285.67M | -0.3% |
| FY 2021 | $286.52M | +66.2% |
| FY 2020 | $172.44M | -1.9% |
| FY 2019 | $175.81M | +161.2% |
| FY 2018 | $67.30M | -47.5% |
| FY 2017 | $128.21M | +6.3% |
| FY 2016 | $120.64M | +6.4% |
| FY 2015 | $113.43M | +6.5% |
| FY 2014 | $106.54M | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | — |
| FY 2009 | $0 | — |
Source: ANI Pharmaceuticals, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for ANI Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeANI Pharmaceuticals, Inc. — frequently asked questions
What is ANI Pharmaceuticals, Inc.'s total debt (short- plus long-term borrowings)?
ANI Pharmaceuticals, Inc. (ANIP) reported total debt (short- plus long-term borrowings) of $291.84M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from ANI Pharmaceuticals, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.